Albert S. Jun

Albert S. Jun

Auto-generated profile, based on publicly available information

Albert S. Jun

Wilmer Eye Institute, Johns Hopkins School of Medicine

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
AJAlbert S. Jun
Albert S. Jun
HMHuan Meng
Huan Meng
NRNaren Ramanan
Naren Ramanan
MMMario Matthaei
Mario Matthaei
SCShukti Chakravarti
Shukti Chakravarti
MKMartha Kimos
Martha Kimos
Fuchs endothelial corneal dystrophy (FECD) is a leading indication for corneal transplantation. FECD is characterized by progressive alterations in endothelial cell morphology, excrescences (guttae) and thickening of the endothelial basement membrane and cell death. Ultimately, these changes lead to corneal edema and vision loss. Due to the lack of vision loss in early disease stages and the decades long disease course, early pathophysiology in FECD is virtually unknown as studies of pathologic tissues have been limited to end-stage tissues obtained at transplant. The first genetic defect shown to cause FECD was a point mutation causing a glutamine to lysine substitution at amino acid position 455 (Q455K) in the alpha 2 collagen 8 gene (COL8A2) which results in an early onset form of the disease. Homozygous mutant knock-in mice with this mutation (Col8a2Q455K/Q455K) show features strikingly similar to human disease, including progressive alterations in endothelial cell morphology, cell loss and basement membrane guttae. Ultrastructural analysis shows the predominant defect as dilated endoplasmic reticulum (ER), suggesting ER stress and unfolded protein response (UPR) activation. Immunohistochemistry, western blotting, quantitative reverse transcriptase polymerase chain reaction and terminal deoxynucleotidyl transferase 2́-deoxyuridine, 5́-triphosphate nick end-labeling analyses support UPR activation and UPR-associated apoptosis in the Col8a2Q455K/Q455K mutant corneal endothelium. This study confirms the Q455K substitution in the COL8A2 gene as being sufficient to cause FECD in the first mouse model of this disease and supports the role of the UPR and UPR-associated apoptosis in the pathogenesis of FECD caused by COL8A2 mutations.

1 February 2010 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CEChristoph Engler
Christoph Engler
CKClare Kelliher
Clare Kelliher
ASArielle R. Spitze
Arielle R. Spitze
CSCaroline L. Speck
Caroline L. Speck
CECharles G. Eberhart
Charles G. Eberhart
AJAlbert S. Jun
Albert S. Jun

1 February 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
AJAlbert Jun
Albert Jun
GVGustavo Vedana
Gustavo Vedana
GJGuadalupe Villarreal Jr.
Guadalupe Villarreal Jr.
Fuchs endothelial corneal dystrophy: current perspectives Gustavo Vedana, Guadalupe Villarreal Jr, Albert S Jun Wilmer Eye Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Fuchs endothelial corneal dystrophy (FECD) is the most common corneal dystrophy and frequently results in vision loss. Hallmarks of the disease include loss of corneal endothelial cells and formation of excrescences of Descemet’s membrane. Later stages involve all layers of the cornea. Impairment of endothelial barrier and pump function and cell death from oxidative and unfolded protein stress contribute to disease progression. The genetic basis of FECD includes numerous genes and chromosomal loci, although alterations in the transcription factor 4 gene are associated with the majority of cases. Definitive treatment of FECD is corneal transplantation. In this paper, we highlight advances that have been made in understanding FECD’s clinical features, pathophysiology, and genetics. We also discuss recent advances in endothelial keratoplasty and potential future treatments. Keywords: Fuchs endothelial corneal dystrophy, corneal endothelial cell, corneal transplantation, Descemet’s stripping automated endothelial keratoplasty, Descemet’s membrane endothelial keratoplasty, endothelial keratoplasty

1 March 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
HMHuan Meng
Huan Meng
MMMario Matthaei
Mario Matthaei
NRNarendrakumar Ramanan
Narendrakumar Ramanan
RGRhonda Grebe
Rhonda Grebe
SCShukti Chakravarti
Shukti Chakravarti
AJAlbert S. Jun
Albert S. Jun
Purpose. We compared the cellular phenotypes and studied the role of autophagy in the pathogenesis of Fuchs endothelial corneal dystrophy (FECD) using two α2 collagen VIII (Col8a2) knock-in mouse models and human FECD tissues. Methods. In vivo corneal endothelial cell (CEC) counts and morphology were analyzed by clinical confocal microscopy. Ultrastructural analysis of CECs was performed by transmission electron microscopy. Real-time PCR and Western blotting were performed using total RNA, and protein extracted from mouse CECs and human CECs obtained from FECD and autopsy patients. Results. Both Col8a2 mouse models exhibited hallmarks of FECD; however, the Col8a2L450W/L450W mice exhibited a milder phenotype compared to the Col8a2Q455K/Q455K mice. Both models exhibited upregulation of the unfolded protein response (UPR) as evidenced by dilated rough endoplasmic reticulum (RER), and upregulation of UPR-associated genes and proteins. Real-time PCR of Col8a2L450W/L450W and Col8a2Q455K/Q455K CECs at 40 weeks revealed a 2.1-fold (P < 0.05) and a 5.2-fold (P < 0.01) upregulation of the autophagy marker Dram1, respectively. Real-time PCR of human FECD endothelium revealed a 10.4-fold upregulation of DRAM1 (P < 0.0001) compared to autopsy controls. Conclusions. The Col8a2L450W/L450W and Col8a2Q455K/Q455K mouse models of FECD showed distinct endothelial cell phenotypes. Dram1 was associated with activation of the UPR and increased autophagy. Overexpression of this gene in mouse and human FECD endothelial cells suggested a role for altered autophagy in this disease.

1 January 2014 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
MMMario Matthaei
Mario Matthaei
JHJianfei Hu
Jianfei Hu
LKLaura Kallay
Laura Kallay
CECharles G. Eberhart
Charles G. Eberhart
CCClaus Cursiefen
Claus Cursiefen
AJAlbert S. Jun
Albert S. Jun
Purpose. MicroRNAs (miRNAs) are a class of endogenous noncoding RNA and post transcriptionally modulate gene expression during development and disease. Our study investigated the differential miRNA expression in human Fuchs' endothelial corneal dystrophy (FECD) compared with normal endothelium to identify miRNA sequences that are involved in the pathogenesis of FECD. Methods. Comparative miRNA expression profiles of endothelial samples obtained from FECD patients during lamellar corneal transplant surgery and from normal donor globes were generated using OpenArray plate technology. Differential expression of individual miRNAs was validated in the original and in independent samples using stem-loop RT qPCR assays. Expression of miRNA target genes was assessed using qPCR and tissue microarray (TMA) immunolabeling. Results. Our results demonstrate downregulation of 87 miRNAs in FECD compared with normal endothelium (>3-fold change; P < 0.01). Correspondingly, DICER1, (encoding an endoribonuclease critical to miRNA biogenesis) showed a moderate but significant decrease in FECD samples (P < 0.05). Significant repression of three miR-29 family members (miR-29a-3p, miR-29b-2-5p, and miR-29c-5p) was paralleled by upregulation of their extracellular matrix associated mRNA targets collagen I and collagen IV. Tissue microarray immunolabeling showed histologically verifiable subendothelial collagen I and collagen IV deposition and increased endothelial laminin protein expression in FECD samples. Conclusions. The present study provides the first miRNA profile in FECD and normal endothelial cells and demonstrates widespread miRNA downregulation in FECD. Decreased endothelial expression of miR-29 family members may be associated with increased subendothelial extracellular matrix accumulation in FECD.

1 May 2015 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
LVLucas M.M. Vianna
Lucas M.M. Vianna
CSChristopher G. Stoeger
Christopher G. Stoeger
JGJoshua D. Galloway
Joshua D. Galloway
MTMark Terry
Mark Terry
LCLeslie Cope
Leslie Cope
AJAlbert S. Jun
Albert S. Jun